Cathy Friedman's Net Worth
$1.89 Million
Who is Cathy Friedman?
Cathy Friedman has an estimated net worth of $1.89 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, Lyell Immunopharma, Inc., THERAVANCE INC, GSV Capital Corp., Seer, Inc., Radius Health, Inc., Revolution Healthcare Acquisition Corp., XENOPORT INC, and YAHOO INC.
SEC CIK
Cathy Friedman's CIK is 0001411874
Past Insider Trading and Trends
2014 was Cathy Friedman's most active year for acquiring shares with 13 total transactions. Cathy Friedman's most active month to acquire stocks was the month of April. 2016 was Cathy Friedman's most active year for disposing of shares, totalling 8 transactions. Cathy Friedman's most active month to dispose stocks was the month of June. 2007 saw Cathy Friedman paying a total of $96,764.40 for 37,000 shares, this is the most they've acquired in one year. In 2022 Cathy Friedman cashed out on 36,800 shares for a total of $304,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
∞
| 11.8K |
$1.70 | $20,071.80 | 11.8K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
∞
| 12K |
$8.06 | $96,764.40 | 12K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -93.75% | -3.55M |
—
|
—
| 236.37K |
Dec 14
| |||
Form 4
|
∞
| 3.78M |
$17.00 | $300,016.00 | 3.78M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
THERAVANCE INC (INVA) Snapshot price: $18.7201
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.81% | 19.86K |
—
|
—
| 73.81K |
Apr 20
| |||
Form 4
| +51.45% | 18.33K |
—
|
—
| 53.95K |
Apr 26
| |||
Form 4
| +64.37% | 13.95K |
—
|
—
| 35.62K |
Apr 24
| |||
Form 4
| +42.85% | 6.5K |
—
|
—
| 21.67K |
Dec 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
|
∞
| 15.17K |
—
|
—
| 15.17K |
Jun 2
| |||
Form 4
|
∞
| 12K |
—
|
—
| 12K |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GSV Capital Corp. (SSSS) Snapshot price: $3.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Seer, Inc. (SEER) Snapshot price: $1.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.62% | 23.44K |
—
|
—
| 173.57K |
Jun 14
| |||
Form 4
| +7.09% | 9.95K |
—
|
—
| 150.13K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |